BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+22.78%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$12.2B
AUM Growth
+$12.2B
Cap. Flow
+$1.32B
Cap. Flow %
10.82%
Top 10 Hldgs %
86.71%
Holding
139
New
5
Increased
21
Reduced
9
Closed
18

Top Buys

1
INCY icon
Incyte
INCY
$1.42B
2
AVXS
AveXis, Inc. Common Stock
AVXS
$14M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
$10.9M
4
ASND icon
Ascendis Pharma
ASND
$9.19M
5
NGNE icon
Neurogene
NGNE
$6.64M

Top Sells

1
ABBV icon
AbbVie
ABBV
$106M
2
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
$19.5M
3
ARRY
Array Biopharma Inc
ARRY
$8.94M
4
EXEL icon
Exelixis
EXEL
$8.67M
5
ARAV
Aravive, Inc. Common Stock
ARAV
$5.56M

Sector Composition

1 Healthcare 92.13%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AGIO icon
51
Agios Pharmaceuticals
AGIO
$2.28B
$7.51M 0.06%
128,666
– –
CFRX
52
DELISTED
ContraFect Corporation
CFRX
$7.28M 0.06%
4,045,876
– –
INSM icon
53
Insmed
INSM
$28.8B
$7M 0.06%
400,000
– –
MGNX icon
54
MacroGenics
MGNX
$110M
$6.76M 0.06%
363,676
– –
ASMB icon
55
Assembly Biosciences
ASMB
$190M
$6.37M 0.05%
250,000
– –
CBAY
56
DELISTED
Cymabay Therapeutics
CBAY
$6.08M 0.05%
1,413,499
+1,104,231
+357% +$4.75M
LOXO
57
DELISTED
Loxo Oncology, Inc
LOXO
$5.8M 0.05%
137,735
– –
AKTX
58
Akari Therapeutics
AKTX
$22.8M
$5.5M 0.05%
496,901
– –
STML
59
DELISTED
Stemline Therapeutics, Inc.
STML
$5.42M 0.04%
633,497
+300,000
+90% +$2.56M
RXDX
60
DELISTED
Ignyta, Inc.
RXDX
$4.91M 0.04%
571,000
– –
ALDR
61
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$4.52M 0.04%
217,328
– –
BIIB icon
62
Biogen
BIIB
$19.4B
$4.51M 0.04%
16,500
– –
NBRV
63
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$4.2M 0.03%
350,000
– –
ANAB icon
64
AnaptysBio
ANAB
$569M
$4.16M 0.03%
+150,000
New +$4.16M
ZGNX
65
DELISTED
Zogenix, Inc.
ZGNX
$4.14M 0.03%
381,939
-456,870
-54% -$4.96M
EPZM
66
DELISTED
Epizyme, Inc
EPZM
$3.99M 0.03%
232,481
– –
RARX
67
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$3.79M 0.03%
177,952
– –
RARE icon
68
Ultragenyx Pharmaceutical
RARE
$2.89B
$3.39M 0.03%
50,000
– –
SYRS
69
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.26M 0.03%
204,465
– –
TRVN
70
DELISTED
Trevena, Inc.
TRVN
$3.15M 0.03%
857,206
+407,206
+90% +$1.49M
VIRX
71
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.04M 0.02%
741,665
– –
ADMS
72
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$3.02M 0.02%
172,630
– –
GNMX
73
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
$3.01M 0.02%
1,618,089
+737,550
+84% +$1.37M
KPTI icon
74
Karyopharm Therapeutics
KPTI
$58.8M
$2.79M 0.02%
216,990
– –
TRIL
75
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.54M 0.02%
413,697
– –
1 2
3
4 5